All updates

All updates

icon
Filter
Management news
Mycorena files for bankruptcy and plans restructuring under new ownership
Plant-based Meat
Jul 16, 2024
This week:
M&A
Creador acquires hospitality marketplace MG Group for undisclosed sum to expand global operations
Travel Tech
Jan 2, 2025
Product updates
Industry news
LeddarTech unveils new AI-driven ADAS platform at CES 2025
Auto Tech
Jan 2, 2025
Partnerships
Ansys and Cognata partner to enable ADAS/AV sensor testing on Microsoft Azure
Auto Tech
Jan 2, 2025
Partnerships
Norma partners with Maybell Quantum to develop quantum computing systems in South Korea
Quantum Computing
Jan 2, 2025
Product updates
Insilico Medicine nominates new preclinical candidate for cancer treatment
AI Drug Discovery
Jan 2, 2025
Partnerships
Atavistik Bio partners with Pfizer to discover precision allosteric therapeutics
Precision Medicine
Jan 2, 2025
Product updates
Neumora's depression drug navacaprant fails first Phase III trial
Precision Medicine
Jan 2, 2025
M&A
Revolution Sustainable Solutions acquires Island Plastics for undisclosed sum
Waste Recovery & Management Tech
Jan 2, 2025
Funding
Infinant raises USD 15 million in Series A funding to expand product offerings
Data Infrastructure & Analytics
Jan 2, 2025
Product updates
Solayer launches LAYER governance token and non-profit foundation
Decentralized Finance (DeFi)
Jan 2, 2025
Plant-based Meat

Plant-based Meat

Jul 16, 2024

Mycorena files for bankruptcy and plans restructuring under new ownership

Management news

  • Mycorena, a Swedish alternative protein producer, has filed for bankruptcy and plans to undergo restructuring under new ownership. The company holds several patents, trademarks, and other valuable assets that could provide lucrative opportunities for potential new owners in the field of alternative ingredients.

  • Magnus Löfving of Advokatfirman Lindahl KB was appointed trustee to manage Mycorena's bankruptcy procedures. This included evaluating the company's assets and seeking interested parties to bid for ownership to continue operations under new management.

  • Analyst QuickTake: As of July 2024, Mycorena had raised a total of USD 37.7 million in funding and even gained financial backing from the European Space Agency's Discovery Programme to develop methods for alternative protein production in space. Despite this, in June 2024 , the company discontinued its planned factory project for its principal mycoprotein ingredient, citing reduced investor interest in high-capital investment projects.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.